Queries slow down TRIPS waiver for Covid drugs; EU pushes own proposal

The European Union pushing its own proposal, lack of enthusiasm to engage in bilateral talks on the waiver proposal and opponents asking country-level implementation questions have slowed the pace of the text-based talks on the proposal seeking patent waivers in the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement, on Covid-19-related medical products.
Source: The Economic Times - Category: Consumer Health News Source Type: news